ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 448

$1.1M Total Retail Price of All Prescriptions

Rank: 17 out of 448

548 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,260 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$131 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
GLIMEPIRIDE 482 389 1 7
METFORMIN HCL 463 320 2 2
LANTUS SOLOSTAR 451 337 3 10
PEN NEEDLE 432 333 4 5
JANUVIA 405 351 5 6
SIMVASTATIN 374 314 6 4
LEVOTHYROXINE SODIUM 367 323 7 1
ATORVASTATIN CALCIUM 365 296 8 13
HUMALOG 356 258 9 11
LANTUS 316 175 10 8
NOVOLOG FLEXPEN 222 151 11 28
LISINOPRIL 214 136 12 14
SYNTHROID 207 116 13 3
CARVEDILOL 150 125 14 36
INSULIN SYRINGE 148 93 15 9
NATEGLINIDE 136 111 16 49
NOVOLOG 132 55 17 34
CRESTOR 128 94 18 22
METHIMAZOLE 125 125 19 24
LOVASTATIN 125 90 19 40
BYETTA 122 95 21 47
LOVAZA 120 66 22 43
LEVOXYL 117 72 23 18
PRANDIN 108 104 24 51
ALENDRONATE SODIUM 102 100 25 17
LEVEMIR FLEXPEN 98 69 26 35
ACTOS 96 64 27 20
AMLODIPINE BESYLATE 92 71 28 12
ZETIA 86 58 29 41
HYDROCHLOROTHIAZIDE 78 62 30 27
GLIPIZIDE 75 56 31 15
PRAVASTATIN SODIUM 70 43 32 31
JANUMET 65 32 33 32
LIPITOR 65 55 33 56
METFORMIN HCL ER 64 45 35 19
CLONIDINE HCL 61 41 36 72
ACARBOSE 52 42 37 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.